03579oam 2200673I 450 991078060320332120230601144458.00-429-19115-41-4200-2029-310.3109/9781420020298(CKB)2440000000014258(EBL)1405525(SSID)ssj0000377516(PQKBManifestationID)11278157(PQKBTitleCode)TC0000377516(PQKBWorkID)10337989(PQKB)11225017(MiAaPQ)EBC1405525(MiAaPQ)EBC863286(Au-PeEL)EBL1405525(CaPaEBR)ebr10231554(CaONFJC)MIL741292(OCoLC)794663351(OCoLC)858014450(Au-PeEL)EBL863286(EXLCZ)99244000000001425820180420d2008 uy 0engur|n|---|||||txtccrPharmaceutical dosage formsTablets3rd ed. /edited by Larry L. Augsburger, Stephen W. Hoag.New York :Informa Healthcare USA,2008.1 online resource (550 p.)Description based upon print version of record.1-336-10006-0 0-8493-9015-X Includes bibliographical references and index.Front Cover; Foreword; Preface; Contents; Contributors; Chapter 1. Mass Transfer from Solid Oral Dosage Forms; Chapter 2. Approaches for Improving Bioavailability of Poorly Soluble Drugs; Chapter 3. Aims and Objectives and of Experimental Design and Optimization in Formulation and Process Development; Chapter 4. Knowledge-based Systems and Other AI Applications for Tableting; Chapter 5. Direct Compression and the Role of Filler-binders; Chapter 6. Disintegrants in Tableting; Chapter 7. Lubricants, Glidants, and Antiadherents; Chapter 8. Surfactants and Colors in TabletsChapter 9. Orally Disintegrating Tablets and Related Tablet FormulationsChapter 10. Formulation Challenges: Multiple Vitamin and Mineral Dosage Forms; Chapter 11. Botanicals and Their Formulation into Oral Solid Dosage Forms; Chapter 12. Formulation of Specialty Tablets for Slow Oral Dissolution; Chapter 13. Formulation and Design of Veterinary Tablets; Chapter 14. Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers; Chapter 15. Carrageenans in Solid Dosage Form Design; Chapter 16. Osmotic Systems; Chapter 17. Tableting of Multiparticulate Modified Release SystemsBack Cover<b><i>Pharmaceutical Dosage Forms: Tablets, Third Edition</i></b>is acomprehensive treatment of the design, formulation, manufacture, and evaluation of the tablet dosage form. The ultimate goal of drug product development is to design a system that maximizes the therapeutic potential of the drug substance and facilitates its access to patients; <b><i>Volume 2</i></b> focuses on the rational design, and formulation of a tablet and includes chapters with practical illustrations and formulation examples.TabletsTablets (Medicine)DrugsDosage formsTablets (Medicine)DrugsDosage forms.615/.1901Augsburger Larry L1500692Hoag Stephen W1500693MiAaPQMiAaPQMiAaPQBOOK9910780603203321Pharmaceutical dosage forms3727491UNINA